发明名称 Methods of treating neuronal inflammation using an IL-31 monoclonal antibody
摘要 Use of antagonists to IL-31 are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues. Such antagonists include antibodies and fragments, derivative, or variants thereof. Symptoms such as pain, tingle, sensitization, tickle associated with neuropathies are ameliorated.
申请公布号 US9334321(B2) 申请公布日期 2016.05.10
申请号 US201514603406 申请日期 2015.01.23
申请人 ZymoGenetics, Inc. 发明人 Yao Yue;Bilsborough Janine
分类号 A61K39/395;A61K38/16;A61K38/00;C07K16/28;C07K14/435;C07K16/24;A61K38/17;A61K39/00 主分类号 A61K39/395
代理机构 代理人 Walsh Brian J.
主权项 1. A method of treating neuronal tissue inflammation in a mammal comprising administering to the mammal a humanized monoclonal antibody derived from the antibody produced by the hybridoma deposited with the American Type Culture Collection having the ATCC Patent Deposit Designation PTA-6815, wherein the humanized monoclonal antibody comprises a human IgG4 heavy chain immunoglobulin constant domain, and wherein after administration the mammal's neuronal tissue inflammation is reduced.
地址 Princeton NJ US